CIK: 0001538653 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value ($000): $1,626,531 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CACC | CREDIT ACCEP CORP MICH | 1,560,014 | $792,378 | 48.7% | $107.75 | +334.3% | COM | 225310101 |
| WRLD | WORLD ACCEP CORP DEL | 2,037,495 | $273,045 | 16.8% | $81.92 | +31.3% | COM | 981419104 |
| W | WAYFAIR INC | 3,823,239 | $248,549 | 15.3% | $53.95 | -21.9% | CL A | 94419L101 |
| CMPR | CIMPRESS PLC | 3,906,492 | $232,358 | 14.3% | $129.96 | -62.1% | SHS EURO | G2143T103 |
| YELP | YELP INC | 918,446 | $33,441 | 2.1% | $30.67 | +5.2% | CL A | 985817105 |
| GIC | GLOBAL INDUSTRIAL COMPANY | 1,071,222 | $29,748 | 1.8% | $32.63 | -27.0% | COM | 37892E102 |
| GRND | GRINDR INC | 2,280,604 | $12,612 | 0.8% | $9.29 | -34.5% | COM | 39854F101 |
| LCTX | LINEAGE CELL THERAPEUTICS IN | 1,851,851 | $2,611 | 0.2% | $1.03 | +34.1% | COM | 53566P109 |
| HUMA | HUMACYTE INC | 568,246 | $1,625 | 0.1% | $6.34 | -43.2% | COM | 44486Q103 |
| — | AGEX THEREPEUTICS INC | 185,185 | $165 | 0.0% | $2.99 | — | COM | 00848H108 |